Anti-ORAI1 antibody DS-2741a, a specific CRAC channel blocker, shows ideal therapeutic profiles for allergic disease via suppression of aberrant T-cell and mast cell activation.
- DOI
- 10.1096/fba.2020-00008
- Published
- 2020 Aug
- Container
- FASEB bioAdvances
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1096/fba.2020-00008,
title = {Anti-ORAI1 antibody DS-2741a, a specific CRAC channel blocker, shows ideal therapeutic profiles for allergic disease via suppression of aberrant T-cell and mast cell activation.},
author = {Aki A and Tanaka K and Nagaoka N and Kimura T and Baba D and Onodera Y and Wada T and Maeda H and Nakanishi T and Agatsuma T and Komai T},
year = {2020},
journal = {FASEB bioAdvances},
doi = {10.1096/fba.2020-00008},
url = {https://doi.org/10.1096/fba.2020-00008}
}RIS
TY - JOUR TI - Anti-ORAI1 antibody DS-2741a, a specific CRAC channel blocker, shows ideal therapeutic profiles for allergic disease via suppression of aberrant T-cell and mast cell activation. AU - Aki A AU - Tanaka K AU - Nagaoka N AU - Kimura T AU - Baba D AU - Onodera Y AU - Wada T AU - Maeda H AU - Nakanishi T AU - Agatsuma T AU - Komai T PY - 2020 JO - FASEB bioAdvances DO - 10.1096/fba.2020-00008 UR - https://doi.org/10.1096/fba.2020-00008 ER -
APA
A, A., K, T., N, N., T, K., D, B., Y, O., T, W., H, M., T, N., T, A., & T, K. (2020). Anti-ORAI1 antibody DS-2741a, a specific CRAC channel blocker, shows ideal therapeutic profiles for allergic disease via suppression of aberrant T-cell and mast cell activation.. FASEB bioAdvances. https://doi.org/10.1096/fba.2020-00008
Source records
- pubmed · retrieved 2026-09-26T18:04:27.607Z